Related Experiment Videos

Does biomodulation of 5-fluorouracil improve results?

A F Sobrero¹, R Herrmann, D Rischin

¹Medical Oncology, University of Udine, Italy.

European Journal of Cancer (Oxford, England : 1990)

|August 17, 1999

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Corrigendum to "Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer": [ESMO Gastrointestinal Oncology, Volume 5, 100069].

ESMO gastrointestinal oncology·2026

Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026

Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma.

Frontiers in oncology·2025

A New Dawn-Using Teletrials for Early Phase Drug Development: A Practical Guideline.

Asia-Pacific journal of clinical oncology·2025

Optimizing Pre-Operative Clinical Staging in Resectable Non-Small Cell Lung Cancer (NSCLC): A Retrospective Cohort Study.

Thoracic cancer·2025

Impacts of a Clinical Quality Registry on Lung Cancer Quality Measures: A Retrospective Observational Study of the Victorian Lung Cancer Registry.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

See all related articles